Skip to content

CHICAGO–(BUSINESS WIRE)–Sept. 2, 2005–Allscripts (Nasdaq:MDRX),
the leading provider of clinical software, connectivity and
information solutions that physicians use to improve healthcare,
announced today that it will host the Company’s 2005 Investor Day on
Thursday, September 8, 2005 in New York City, New York. The Investor
Day will occur from 9:00 AM to 12:00 PM EDT and will be broadcasted
via audio cast.

The Investor Day audio cast can be accessed by dialing
877-237-9751, ID #9323871 (International Dial-in 706-679-4288). An
encore presentation will be available approximately 72-hours after of
the call for a period of 30-days at www.allscripts.com or by calling
800-642-1687, ID #9323871 (International Dial-in 706-645-9291).

About Allscripts

Allscripts is the leading provider of clinical software,
connectivity and information solutions that physicians use to improve
healthcare. The Company provides unique solutions that inform,
connect, and transform healthcare. The Clinical Solutions Group’s
award-winning clinical software applications include Electronic Health
Record, e-prescribing and document imaging solutions. Allscripts’
Physicians Interactive Group provides clinical product education and
connectivity solutions for physicians and patients. The Company’s
Medication Services Group provides medication fulfillment services. To
learn more, visit Allscripts on the Web at www.allscripts.com.

This announcement may contain forward-looking statements about
Allscripts Healthcare Solutions that involve risks and uncertainties.
These statements are developed by combining currently available
information with Allscripts beliefs and assumptions. Forward-looking
statements do not guarantee future performance. Because Allscripts
cannot predict all of the risks and uncertainties that may affect it,
or control the ones it does predict, Allscripts’ actual results may be
materially different from the results expressed in its forward-looking
statements. For a more complete discussion of the risks, uncertainties
and assumptions that may affect Allscripts, see the Company’s 2004
Annual Report on Form 10-K, available through the Web site maintained
by the Securities and Exchange Commission at www.sec.gov.


    CONTACT: Allscripts
             Dan Michelson, 312-506-1217
             dan.michelson@allscripts.com
             Bill Davis, 312-506-1211
             bill.davis@allscripts.com

    SOURCE: Allscripts
Scroll To Top